SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-13-051379
Filing Date
2013-09-18
Accepted
2013-09-18 13:07:55
Documents
3
Period of Report
2013-09-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v355376_8k.htm 8-K 19697
2 EXHBIT 99.1 v355376_ex99-1.htm EX-99.1 7421
3 GRAPHIC image_001.jpg GRAPHIC 1921
  Complete submission text file 0001144204-13-051379.txt   31073
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)

IRS No.: 223542636 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15697 | Film No.: 131103164
SIC: 2834 Pharmaceutical Preparations